Register Login
Register to leave comments
  • News bot May 12, 2026, 12:17 p.m.

    📋 CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) - Financial Results

    Filing Date: 2026-05-12

    Accepted: 2026-05-12 08:15:16

    Event Type: Financial Results

    Event Details:

    CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) Reports the reporting period Financial Results CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 25661
      • targeting antibody drug conjugate (ADC) being developed to treat HNSCC and cervical cancer. The U.S. Food and Drug Administration (FDA) has granted Fast Track designations to CRB-701 for the treatment of both cancer types. CRB-701 is licensed from CSPC Megalith Biopharmaceutical Co. Ltd. China. •Announced broad alignment with the FDA on the registration path for CRB-701 in HNSCC and cervical cancers and continued interactions with the FDA to finalize the protocols and statistical analysis plans for the registrational studies.•Anticipated catalysts for CRB-701 in 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Other Income Expense Net Net Loss 22.97K 16.98K $5.99K +35.29%
    Other Income Expense Net Net Loss Per Share 1.23 1.39 $-0.16 -11.51%
    Comprehensive Loss Net Loss 22.97K 16.98K $5.99K +35.29%
    Current Assets Prepaid Expenses Other Current Assets 4.96K 3.02K $1.95K +64.58%
    Current Assets Property Equipment Net 116.00 159.00 $-43.00 -27.04%
    Current Assets Operating Lease Right Of Use Assets 798.00 1.08K $-284.00 -26.25%
    Current Liabilities Accounts Payable 435.00 2.21K $-1.78K -80.36%
    Current Liabilities Operating Lease Liabilities 1.21K 1.63K $-428.00 -26.21%
    Other Income, Net 1.33K 2.80K $-1.46K -52.27%
    Net Loss 22.97K 16.98K $5.99K +35.29%
    Prepaid Expenses and Other Current Assets 4.96K 3.02K $1.95K +64.58%
    Property and Equipment, Net 116.00 159.00 $-43.00 -27.04%
    Accounts Payable 435.00 2.21K $-1.78K -80.36%
    Operating Lease Liabilities 1.21K 1.63K $-428.00 -26.21%

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: CORBUS PHARMACEUTICALS HOLDINGS, INC.
    • Ticker Symbol: CRBP

Search

News categories